HearingAssist Control vs Resound Vivia 9 60S microRIE

The HearingAssist Control is a behind-the-ear OTC hearing aid priced at $549, earning a B grade with a SoundScore of 3.3/5 in our lab testing. This places it in the lower portion of the OTC category, ranking #51 of 65 devices tested. In our testing, the Control demonstrates notable strengths in speech performance. Speech in quiet scores 0.59 points above the category average at 3.4/5, representing solid absolute performance. Speech in noise comes in at 2.0/5—above the category average by 0.56 points, though only mixed in absolute terms. Feedback handling is excellent at 5.0/5, meaning the device remained stable without audible squealing during our standardized challenge tests. The device shows significant weaknesses in other areas. Music streaming scored 0.0/5, which is 1.92 points below the category average and indicates this device does not support or perform well with phone audio streaming. Own-voice comfort is also below average at 2.1/5 (0.41 points below category average), which may be noticeable during extended conversations. The HearingAssist Control may suit users who prioritize speech clarity over streaming functionality and who don't require premium sound quality across all use cases. However, buyers in this price range should note that several competitors—including the Yeasound RIC800 and Sony CRE-E10—deliver substantially higher overall scores. Those seeking similar speech performance at a lower cost may also consider the iHear MatriX.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.